AGP Picks
View all

Healthcare Wire Texas
Provided by AGP

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 26, 2026

Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas
Oct. 26, 2026

Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas

Indeterminate GlobeNewswire
Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component
Oct. 26, 2026

Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component

Indeterminate GlobeNewswire
Affordable Pet Labs Launches Nationwide Validation Study of an At-Home Heartworm Test, and Invites Dog Owners in 52 Cities to Help
Oct. 26, 2026

Affordable Pet Labs Launches Nationwide Validation Study of an At-Home Heartworm Test, and Invites Dog Owners in 52 Cities to Help

Indeterminate GlobeNewswire
Stryker completes acquisition of ZuriMED to enhance its shoulder offering
Oct. 26, 2026

Stryker completes acquisition of ZuriMED to enhance its shoulder offering

Indeterminate GlobeNewswire
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
Oct. 26, 2026

GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting

Indeterminate GlobeNewswire
Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026
Oct. 26, 2026

Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026

Indeterminate GlobeNewswire
Seismic Therapeutic to Participate in Upcoming Investor Conferences
Oct. 26, 2026

Seismic Therapeutic to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature
Oct. 26, 2026

Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature

Indeterminate GlobeNewswire
Novastra Therapeutics Reports Encouraging First Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at ESMO Congress 2026
Oct. 26, 2026

Novastra Therapeutics Reports Encouraging First Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at ESMO Congress 2026

Indeterminate GlobeNewswire
TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years
Oct. 26, 2026

TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years

Indeterminate GlobeNewswire
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Oct. 26, 2026

Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline

Indeterminate GlobeNewswire
BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop
Oct. 26, 2026

BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop

Indeterminate GlobeNewswire
Amwell® to report third quarter 2026 operating results
Oct. 26, 2026

Amwell® to report third quarter 2026 operating results

Indeterminate GlobeNewswire
Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer
Oct. 26, 2026

Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer

Indeterminate GlobeNewswire
Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia
Oct. 26, 2026

Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia

Indeterminate GlobeNewswire
Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain
Oct. 26, 2026

Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain

Indeterminate GlobeNewswire
Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP
Oct. 26, 2026

Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP

Indeterminate GlobeNewswire
Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026
Oct. 26, 2026

Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026

Indeterminate GlobeNewswire
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Oct. 26, 2026

Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC

Indeterminate GlobeNewswire
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
Oct. 26, 2026

BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.